Home
Clinical Trials
Partnerships
Contact Us
News & Resources
Careers
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Disease
Oncology
Our Product
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Science
Investors
Press Releases
Events and Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Diseases
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Product
Our Science and Technology
News and Resources
News
Posters
Publications
Videos
Investors
Press Releases
Company Information
Corporate Governance
Events and Presentations
SEC Filings
Stock Information
Careers
Partnerships
Contact Us
Search our website
Thermostable Platform
VBI Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability
February 9th, 2016
U.N. Officials Take Steps to Rebuild Vaccine Cold Chain in War-Torn South Sudan
October 2nd, 2015
Surveying the Impact of Accidental Freezing in the Vaccine Cold Chain
June 8th, 2015
Cold Chain Failure Suspected in Rabies Death
May 5th, 2015
VBI Announces Research Collaboration with Sanofi Pasteur to Enhance Vaccine Stability
April 6th, 2015
Heat Degradation Blamed for Reduced H1N1 Vaccine Potency
March 23rd, 2015
Cold Chain Failures Cited in Study Examining Poor Measles Vaccine Potency
February 26th, 2015
Exploring Alternatives to the Cold Chain Delivery System in China
February 3rd, 2015
Vaccine Storage Guidelines Underscore the Challenges of Cold Chain Maintenance
January 15th, 2015
Thermostable Vaccine Contributes to the Reduction of Meningitis A
December 11th, 2014
Thermostable Vaccines: Overview and Market Opportunity
September 18th, 2014
Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI
Sign Up Now